Kedia purchased over 10.60 lakh shares in Mahamaya Lifesciences via his investment arm, Kedia Securities Private Limited. Listed in November 2025, the SME company shares are currently hovering around Rs 175 on the BSE, down by Rs 2.35 or 1.33% over the Monday closing price.
The company was incorporated in 2002 and is engaged in manufacturing, registration and export of crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity. The company specialises in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).
Its IPO was launched in November last year at a price band of Rs 108-114 per share. The stock witnessed a lacklustre debut, getting listed at Rs 115. At the CMP, the stock has delivered 57% returns over the issue price.
Meanwhile, he purchased nearly 15 lakh shares of SPML Infra in the quarter gone by. SPML is an infrastructure company that delivers smart water solutions.
Also read: Dolly Khanna adds a multibagger and a smallcap in March quarter. Check details
SPML has been in momentum for the past month, rallying 26% in this period and shedding its long underperformance. Its one-year returns are flat.Kedia’s portfolio is among the most followed in the Indian market. The marquee investor started his investment journey at the age of 19 and founded Kedia Securities in 1992, when he was 33, according to Trendlyne. As per the latest corporate shareholdings compiled by Trendlyne, Kedia publicly holds 20 stocks with a net worth of over Rs 1,177 crore.
Some of his other major bets include Atul Auto, Elecon Engineering, Global Vectra, Neuland Laboratories, Patel Engineering, Siyaram Silk Mills and TechD Cybersecurity.
(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)